LYOPLANT ONLAY 2.5X2.5CM 1067010

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-02-25 for LYOPLANT ONLAY 2.5X2.5CM 1067010 manufactured by Aesculap Ag.

Event Text Entries

[180809582] Manufacturing site evaluation: investigation on-going. Additional information / investigation results will be provided in a supplemental report, if applicable.
Patient Sequence No: 1, Text Type: N, H10


[180809583] It was reported that there was an issue with a lyoplant onlay, per information provided by medwatch 5092414. The patient had a dura substitute, lyoplant, initially implanted for chiari decompression. Sometime later, the patient presented with subdural hygromas and septic meningitis. This resulted in the need for hospitalization. Additional information was not received. The adverse event is filed under (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2916714-2020-00049
MDR Report Key9751419
Date Received2020-02-25
Date of Report2020-02-25
Date of Event2019-12-12
Date Facility Aware2020-02-03
Report Date2020-01-22
Date Reported to FDA2020-01-22
Date Added to Maude2020-02-25
Event Key0
Report Source CodeDistributor report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationRISK MANAGER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLYOPLANT ONLAY 2.5X2.5CM
Generic NameDURA REPLACEMENT
Product CodeGXQ
Date Received2020-02-25
Model Number1067010
Catalog Number1067010
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerAESCULAP AG
Manufacturer AddressPO BOX 40 TUTTLINGEN, 78501 GM 78501


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2020-02-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.